Peter Humaidan answers a practical question: which endometrial preparation for a fresh transfer (fresh ET) gives the best outcome? He begins with the physiology of the natural cycle as a baseline.
In a natural cycle, ovulation, corpus luteum formation and its progesterone support are synchronised. In a stimulated cycle this synchronisation is disturbed — and this is where the problems of fresh transfer arise.
The key factor is the choice of trigger. Humaidan examines how hCG and the GnRH agonist affect the endometrium differently, and the subsequent corpus luteum function, and thus readiness for implantation.
A GnRH-agonist trigger produces a more physiological but short LH and FSH surge; the corpora lutea then function more weakly, which for a fresh transfer is critical for the luteal phase.
Hence the central thesis: with fresh ET the luteal phase almost always needs support. Without adequate progesterone the endometrium does not reach the required secretory transformation by the time of transfer.
Humaidan names a landmark — a progesterone threshold of about 10 ng/mL. Below this value the chance of success falls, and it is a reason to adjust support rather than to "observe."
The practical point is to measure, not assume: monitoring serum progesterone identifies patients with an insufficient level and allows support to be strengthened or changed in time.
Humaidan links the choice between fresh and deferred (frozen) transfer precisely to the controllability of the luteal phase and to risk: where synchronisation is hard to hold, segmenting the cycle may be wiser.
The Q&A with the moderator is integrated into the lecture and clarifies practical details — timing of measurements, choice of progesterone form and strategy at borderline values.
The overall logic of the talk is to restore controllability to fresh transfer through an understanding of physiology: not to fight the stimulated cycle but to compensate for its known weak points.
Humaidan stresses that the trigger and luteal support are a single system: having chosen an agonist trigger for safety, the clinician must plan reinforced support in advance, or the safety gain turns into an implantation loss.
The practical takeaway for the clinic is to protocolise transfer-day progesterone measurement and to have a ready rescue plan (changing the form or adding a route), rather than adjusting support "by eye" after a negative result.
The upshot: the best preparation for fresh ET is control of the trigger and the luteal phase with a target progesterone of ≈10 ng/mL; measurement and timely correction matter more than a "standard" support regimen.
Why does luteal progesterone matter just as much in fresh cycles as in frozen? A walk-through of trigger choice, mid-luteal cut-offs and rescue strategies for the suboptimal corpus luteum — built on more than 15 years of randomised trials.
Professor Peter Humaidan is Professor in Reproductive Endocrinology at the Fertility Clinic, Skive Regional Hospital, Aarhus University, Denmark. He is internationally recognized for his work in individualized ovarian stimulation, ovulation triggering, and luteal phase physiology, and is co-founder of both the POSEIDON concept and the APHRODITE criteria.
Author of the lecture "Endometrial preparation for fresh embryo transfer"
Patients arrive at the clinic already having consulted ChatGPT, and regulators are reviewing the first AI ‘doctors’. What in artificial intelligence already works in reproductive medicine — from assistant avatars to embryo assessment and stimulation personalisation? A live discussion on three levels — strategy, service and clinic — with practical cases and a panel Q&A.
A Sona-Pharm grant award for specialists in infertility treatment. Applications open on 1 February 2027. Ceremony — July 2027, Stockholm, during the ESHRE meeting.
Targeted, biomarker-guided immunotropic therapy in reproductive medicine. A lecture by Kseniia Khazhylenko at the UARM Symposium 2026.
Audio: UASubtitles: UA32 min
-1.png&w=3840&q=75)
